Listen "ELIOS - What does the data tell us?"
Episode Synopsis
In this episode of the Interventional Glaucoma Podcast, Prof. Gus Gazzard is joined by Prof. Cédric Schweitzer and Dr. Marc Töteberg-Harms to explore what the data tell us about interventional glaucoma. They discuss the robustness of Elios peer-reviewed evidence on efficacy, safety, and long-term outcomes, the crucial role of high-quality data in guiding everyday clinical decisions, and the continued commitment to ongoing research and future data collection in glaucoma care.
The ELIOS system (Bausch & Lomb) is manufactured by MLase GmbH, located at 82110 Germering, Industriestr. 17, Germany and by WEINERT Fiber Optics GmbH, Mittlere-Motsch-Strasse 26, 96515 Sonneberg, Germany.
ELIOS is CE marked for use in adult patients with glaucoma and is currently under investigational use in the US as part of an ongoing IDE study (FDA). The ExTra II (laser class 4) has the brand name ELIOS. The ExTra II is equivalent to ExTra and AIDA devices.
Find out more about ELIOS : http://bit.ly/4lWBJZ1
The ELIOS system (Bausch & Lomb) is manufactured by MLase GmbH, located at 82110 Germering, Industriestr. 17, Germany and by WEINERT Fiber Optics GmbH, Mittlere-Motsch-Strasse 26, 96515 Sonneberg, Germany.
ELIOS is CE marked for use in adult patients with glaucoma and is currently under investigational use in the US as part of an ongoing IDE study (FDA). The ExTra II (laser class 4) has the brand name ELIOS. The ExTra II is equivalent to ExTra and AIDA devices.
Find out more about ELIOS : http://bit.ly/4lWBJZ1
More episodes of the podcast The Interventional Glaucoma Podcast
Health Economics in Interventional Glaucoma
03/12/2025
Excimer fundamentals
19/11/2025
Routine Phaco+ MIGS: Are we there yet?
04/12/2024
Glaucoma Management Five Years from Now
04/11/2024
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.